True North Therapeutics Competitors and Similar CompaniesClear all

True North Therapeutics's competitors and similar companies include Levicept, ROCAtest, Aldeyra Therapeutics and Synexus.

	True North Therapeutics True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.	Levicept Levicept Ltd. develops biological agent for the treatment of chronic pain	ROCAtest ROCAtest (also known as Abcodia) is an innovative biotech company engaged in the validation and discovery of molecular biomarkers.	Aldeyra Therapeutics Aldeyra Therapeutics develops drug candidates for capturing and removing free aldehydes to treat and prevent diseases.	Synexus Synexus is a provider of patient recruitment, trial planning, management, and patient retention services.
Founding Date	Founding Date 2013	Founding Date 2012	Founding Date 2010	Founding Date 2004	Founding Date 1992
Type	Type Subsidiary	Type Private	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech clinics	Tags Healthcare biotech clinics	Tags Healthcare biotech clinics	Tags Healthcare biotech clinics	Tags Healthcare biotech clinical research clinics
Locations	Locations South San Francisco, US HQ	Locations Sandwich, GB HQ	Locations Leeds, GB HQ Royston, GB Boston, US Memphis, US	Locations Lexington, US HQ	Locations Waterloo, GB HQ Wrocław, PL Tempe, US
Employees	Employees 9	Employees N/A	Employees 29	Employees 1958% increase	Employees 3993% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) £568.3k (FY, 2015)	Revenue (est.) N/A	Revenue (est.) £88.6m (FY, 2019)
Cost of goods	Cost of goods N/A	Cost of goods £3.3m (FY, 2015)	Cost of goods £28.5k (FY, 2015)	Cost of goods N/A	Cost of goods £88.1m (FY, 2019)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit £539.7k (FY, 2015)	Gross profit N/A	Gross profit £411k (FY, 2019)
Net income	Net income N/A	Net income (£3.7m) (FY, 2015)	Net income (£2.7m) (FY, 2015)	Net income ($33.8m) (FY, 2025)	Net income (£11.3m) (FY, 2019)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 3.9m (over 11 years ago)	Latest funding round $ 8.3m (about 11 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 164m	Total funding raised $ 16.1m	Total funding raised $ 17m	Total funding raised $ 7.8m	Total funding raised N/A